**Introduction:** Pain is a recurrent theme seen within the rheumatology specialty, usually associated with focal joint manifestation. However the specialty is broad and covers connective tissue disorders which may not be joint specific. This particular case revolved around a patient with known sarcoidosis who presented following a loss of consciousness episode and had been experiencing worsening headache symptoms.

**Case description:** A 42 year old female who presented following a loss of consciousness event and headache symptoms. She had a known background of respiratory sarcoidosis with associated sinonasal disease, with previous diagnosis of necrotic granulomatous sinus inflammation. She had been experiencing headaches however these had recently been worsening in the weeks prior to presentation. She was admitted on the day of presentation following an apparent loss of consciousness episode which had self-resolved and was unwitnessed. On admission, clinical examination was unremarkable with no objective neurological findings, patient was apyrexial. Blood results were similarly non-specific with CRP \<5 and ESR 5. In view of ongoing headaches and the apparent loss of consciousness episode prior to admission, an initial CT head scan was arranged. Radiological findings appeared to suggest the presence of bi-temporal frontal white matter oedema with the report describing appearances suspicious for encephalitis/parenchymal inflammation. In view of potential encephalitis, lumbar puncture was performed to review potential underlying infective pathology. No evidence of bacterial/viral organisms were identified. CSF white and red cell counts were within normal range, however CSF protein levels were noted to be raised at 1.11g/L (0.15 -- 0.45). Further assessment was arranged via MRI head scan. This was reported to show extensive cerebral oedema within the frontal lobes bilaterally with evidence of high T2 signal. Pachymeningeal enhancement of the frontal lobes bilaterally post-gadolineum administration, extending along the falx region towards the central sulcus was also identified. In view of her known history of sarcoidosis, a potential differential of neurosarcoidosis with recommendation of neurology team referral. Incidental finding of extensive mucosal thickening in the maxillary sinuses consistent with the patient's sinonasal disease was also identified. In view of the MRI report, Angiotensin Converting Enzyme (ACE) levels were checked and returned significantly raised at 108u/L (20-70). Prior reading taken approximately a year prior was within normal range at 52u/L (20-70). Joint neurological and rheumatological review concluded likely neurosarcoidosis. Management involved initiation of high dose steroid therapy consisting of a prednisolone dosage of 40mg once daily (calculated as approximately 0.5mg/kg). During her inpatient stay, headache symptoms improved with simple and weak opioid analgesia. No neurological or further loss of consciousness episodes occurred throughout admission. She remained stable and was discharged shortly after. Follow up shortly after in the community (approximately 1 week via phone consultation and 1 month in rheumatology clinic) demonstrated maintenance of clinical stability. Prednisolone dosage was gradually weaned over time. Repeat ACE levels taken a month following discharge returned a value within normal range of 33u/L (20-70).

**Discussion:** Headaches are a common and non-specific symptom. Underlying causes are not always found and are often simply managed symptomatically. In the context of a loss of consciousness episode however, clinicians would be expected to investigate for potential pathological cause that may require intervention. In this particular case, diagnosis was largely achieved via imaging. However additional investigations such as raised ACE levels and raised CSF protein in context of the patient\'s background of sarcoidosis, helped support the underlying diagnosis of neurosarcoidosis. Management via early high dose steroid therapy is important to help manage initial inflammation and in order to prevent further injury, and collaborative input via the neurology team can prove beneficial for specialist input if required in such cases.

**Key learning points:** Neurosarcoidosis is a rare disorder with an estimated incidence of 5% in sarcoidosis patients. However, especially in cases of known sarcoidosis, it remains an important differential should a patient present with neurological symptoms. Definitive diagnosis is ideally via biopsy, however this may not always be possible, Use of imaging as well as markers for sarcoidosis may be beneficial in achieving diagnosis. Should neuorsarcoidosis be suspected or confirmed, then early intervention such as via prednisolone management should be initiated to settle underlying inflammation.
